Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to facilitate well-planned clinical trials across the cancer prevention and control spectrum. The program aims to improve prevention, interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors. The grant will support preparatory studies to fill information gaps and address unknowns, improving trial design and knowledge of trial feasibility. Key aspects of the program include: • Improving cancer prevention and control through clinical trials • Supporting preparatory studies to inform trial design and feasibility • Enhancing trial planning and conduct to improve cancer-related health outcomes • Fostering collaboration and innovation in cancer research The opportunity is open to various types of applicants, including state governments, local governments, public and private institutions of higher education, non-profits, and for-profit organizations.